new BindingDB logo
myBDB logout
Solution Informationhelp
Enzyme: large T antigen
inhibitor: BDBM60389
substrate: n/a
 
Solution Type: Aqueous
pH at Preparation: n/a
Temp. Prep.: n/a
Comments: Primary Assay Conditions: The assay was conducted in 1536-well black, clear-bottom microplates. Assay buffer was 100mM Tris-HCl, 20mM KCl, 6mM MgCl2, and 0.1mg/mL BSA, pH 7.4. Initially, 250nl of test compound (20uM final concentration) in 4% DMSO/assay buffer was added to the respective plate wells. Total reaction volume (without endpoint reagent) was 1.25ul. Total read volume (with endpoint reagent) was 5 ul. Enzyme and buffer volumeswere dispensed using a BioRAPTR FRD (Beckman Coulter, Fullerton, CA). Compounds were dispensed using an Echo 500 Series Liquid Handler (Labcyte, Sunnyvale, CA). Purified TAg was diluted to a concentration of 0.0144 ug/ul in assay buffer. 750nl of TAg (14.4ng/ul, 10.8ng total) in assay buffer was added to each well and allowed to incubate for 30m at ambient temperature. Following incubation, 250nl of 5mM ATP (A7699, Sigma-Aldrich, St. Louis, MO) in assay buffer was added to the respective wells, and incubated for 120m at ambient temperature. Final DMSO c
 
 

If you find an error in this entry please send us an E-mail
   
    

Home

|

Search

|

Deposit

|

SiteMap

|

About us

|

Email us

|

Info

 
Last update November 1, 2007
©2000 BindingDB. All rights reserved.